Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events.
Saved in:
| Title: | Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events. |
|---|---|
| Authors: | Schwarz, Carsten1 (AUTHOR) carsten.schwarz@charite.de, Sutharsan, Sivagurunathan2 (AUTHOR), Epaud, Ralph3 (AUTHOR), Klingsberg, Ross C.4 (AUTHOR), Fischer, Rainald5 (AUTHOR), Rowe, Steven M.6 (AUTHOR), Audhya, Paul K.7 (AUTHOR), Ahluwalia, Neil8 (AUTHOR), You, Xiaojun7 (AUTHOR), Ferro, Thomas J.7 (AUTHOR), Duncan, Margaret E.8 (AUTHOR), Bruinsma, Bote G.8 (AUTHOR) |
| Source: | Journal of Cystic Fibrosis. Mar2021, Vol. 20 Issue 2, p228-233. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15691993 |
|---|---|
| DOI: | 10.1016/j.jcf.2020.06.001 |
